Skip to main content
All lobbying filings

BALLARD SPAHR LLP

BALLARD SPAHR LLP filed a Q2 report for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) on July 21, 2025, reporting $40,000 in lobbying income.

Lobbying for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · ​Pharmaceutical sourcing and distribution services company

All filings by BALLARD SPAHR LLP · Everything CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
Pennsylvania

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Recognizing pharmacists as providers within Medicare COVID-19 response; H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2)

Pharmacy

H.R. 1319- American Rescue Plan Act of 2021 (Public Law No. 117-2); Proposals relating to the Strategic National Stock Pile; COVID-19 vaccine distribution; H.R. 5376- Build Back Better Act; H.R 2870 Essential Medicines Strategic Stockpile Act of 2021-provisions related to medical supply chains and strategic stock piles; H.R. 1770/ S. 2477- Equitable Community Access to Pharmacists Services Act; potential solutions to drug shortages

 Bills named in this filing 5
  • H.R. 1319
    American Rescue Plan Act of 2021
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
  • H.R. 2870
    Essential Medicines Strategic Stockpile Act of 2021
  • H.R. 1770
    Equitable Community Access to Pharmacist Services Act
  • S. 2477
    Equitable Community Access to Pharmacist Services Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem